Navigation Links
Structure of cell signaling molecule suggests general on-off switch
Date:4/21/2013

esearchers were able to isolate and capture the beta-arrestin1 protein in an active state as it binds to a segment of the GPCR a first. That snapshot, in high resolution, revealed that the structural conformation or shape of the protein in its active state is strikingly different than when it is inactive.

Such changes suggest there may be a general molecular mechanism that activates the beta-arrestin1 a sort of main switch that controls the multi-functional signaling proteins.

"It's like there are brakes on in beta-arrestin1, and then when the beta-arrestin1 binds to a GPCR, the brakes are released, thereby activating beta-arrestin1," said Arun K. Shukla, PhD, assistant professor of medicine at Duke and co-lead author of the study.

The researchers are now pursuing additional structural imaging of the signaling complex consisting of beta-arrestin1 and the entire receptor protein.


'/>"/>

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. Study led by NUS researchers proves the existence of 3 overstretched DNA structures
2. Mainz scientists confirm original tetrahedral model of the molecular structure of water
3. A*STAR scientists groundbreaking discovery of nucleus structure crucial to understanding diseases
4. Newly discovered plant structure may lead to improved biofuel processing
5. Nanostructures with living cells
6. Protein structure: Immune system foiled by a hairpin
7. Novel technique reveals dynamics of telomere DNA structure
8. Scientists discover structure of protein essential for quality control, nerve function
9. Banded mongooses structure monosyllabic sounds in a similar way to humans
10. New study defines the long-sought structure of a protein necessary for cell-cell interaction
11. Nanoengineers can print 3D microstructures in mere seconds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... of bacterial infections, including MRSA and MSSA could ... bumps that mimic the scaly surface of shark ... access journal Antimicrobial Resistance and Infection Control ... materials prevented the spread of human disease bacteria ... Sharklet, is an arrangement of ridges formulated to ...
(Date:9/16/2014)... Ohio (September 17, 2014)The North American Menopause Society ... the comprehensive care of midlife womenon everything from ... "The North American Menopause Society Recommendations for Clinical ... in the Society,s journal Menopause . This ... for the care of midlife women freely available ...
(Date:9/16/2014)... Fire began on September 13, 2014. The fire is ... currently over 2,300 acres in size and is mostly ... Fire was calm Monday night due to higher humidity. ... point and beginning to construct a fireline on the West ... are working on the fire: , 7 20-person Crews, 4 ...
Breaking Biology News(10 mins):Sharks' skin has teeth in the fight against hospital superbugs 2
... UT Southwestern Medical Center researchers have identified compounds ... disease, a finding that may eventually lead to a ... degenerative nerve disorders. "Our studies have uncovered a ... for other neurodegenerative diseases," said Dr. Ilya Bezprozvanny, professor ...
... A new study conducted by a team of ... light on a possible new approach to treat the ... enzyme that connects extracellular fibers. The study, published online ... the direction of Katya Ravid, PhD, professor of medicine ...
... MARC (Minority Access to Research Careers) Program has announced the ... of Reproduction (SSR) Annual Meeting in Portland, Oregon from July ... to promote the entry of underrepresented minority students, postdoctorates and ... to encourage the participation of young scientists at the 2011 ...
Cached Biology News:Compound may provide drug therapy approach for Huntington's disease 2BUSM study identifies new potential approaches to treat myelofibrosis 2
(Date:9/18/2014)... San Diego, CA (PRWEB) September 18, 2014 ... promotions which include Sartorius/Biohit, Socorex, Capp, and ... working with volumes of 100 uL or less ... pharmaceutical, oncology, and forensic applications. , The ... of high quality and economic alternative products to ...
(Date:9/17/2014)... INCLINE VILLAGE, Nev. , Sept. 17, 2014  PDL ... notified by its independent registered accounting firm, Ernst & Young ... The resignation was confirmed in a letter delivered to the ... 8-K filed on September 16, 2014.  PDL ... "We have received a number of inquiries on ...
(Date:9/17/2014)... SEATTLE, WA , Sept. 17, 2014 /PRNewswire/ - ... that it intends to offer and sell shares of ... in separate but concurrent underwritten public offerings.  The Series ... shares of Oncothyreon Common Stock, provided that conversion will ... its affiliates would beneficially own more than 4.99% of ...
(Date:9/17/2014)... COLUMBIA, Md. (PRWEB) September 17, 2014 ... Nexera-e Comprehensive Two-Dimensional Liquid Chromatograph (2D-LC), which ... most complex sample matrices. The system provides ... of sample analytes, which is beneficial to ... food extracts, and natural products. , Comprehensive ...
Breaking Biology Technology:Major Pipette Distributor Pipette.com Announces Promotions on Sartorius/Biohit, Socorex, Capp, and AccuPet Micropipettes 2Major Pipette Distributor Pipette.com Announces Promotions on Sartorius/Biohit, Socorex, Capp, and AccuPet Micropipettes 3PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors 2PDL BioPharma Issues Statement on Resignation of Ernst and Young as Corporate Auditors 3Oncothyreon Announces Proposed Public Offerings 2Shimadzu’s New Nexera-e Two Dimensional Comprehensive Liquid Chromatograph Empowers Laboratories to Separate Even the Most Complex Mixtures 2
... 5, 2011 TetraLogic Pharmaceuticals , a biopharmaceutical ... treat cancer, today announced the initiation of a Phase ... candidate, TL32711, in elderly patients with acute myelogenous leukemia ... Hospital of the University of Pennsylvania and is an ...
... FRANCISCO, Calif., Dec. 5, 2011 diaDexus, Inc. (OTC ... focused on the development and commercialization of patent-protected ... cardiovascular disease, today said that it plans to present ... Metabolic Disorders Conference on Tuesday, December 6, 2010 at ...
... Corp. announced today that Wayne R. Gombotz, Ph.D. has ... Officer.  Dr. Gombotz brings a significant amount of ... at Immune Design.  He will oversee product development ... candidates. (Logo: http://photos.prnewswire.com/prnh/20111018/SF88252LOGO ...
Cached Biology Technology:TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML) 2TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML) 3Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer 2
... were designed for full-length gene cloning and ... identify the desired cDNA clone. The first ... "Master Plate," where each well contains plasmid ... positive well(s) by gel electrophoresis of the ...
... The Rapid-Screen cDNA Library Panels were ... just three sets of PCRs to identify ... analysis is performed in a 96-well "Master ... from 5,000 clones. Having identified the positive ...
... The DSQ II (Dual-Stage Quadrupole) ... the world leader in analytical instrumentation, introduces ... the DSQ II. Based on the ... DSQ and PolarisQ GC/MS systems, the DSQ ...
... Panels were designed for full-length gene cloning ... to identify the desired cDNA clone. The ... 96-well "Master Plate," where each well contains ... the positive well(s) by gel electrophoresis of ...
Biology Products: